Nicholas Grund Insider Trading $AVM AMAG PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nicholas Grund.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nicholas Grund. Nicholas Grund is Chief Commercial Officer in AMAG PHARMACEUTICALS INC. ($AVM).
Nicholas Grund in AMAG PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Nicholas Grund: Chief Commercial Officer
Holdings: 73,787 shares
Latest Transaction: Feb 27 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Nicholas Grund in AMAG PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Option Exercise | A | 15.51 | 25,000 | 387,750 | 25,000 | |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Grant | A | 0.00 | 12,000 | 0 | 85,787 | 73.8 K to 85.8 K (+16.26 %) |
| Feb 27 2019 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Grant | A | 0.00 | 12,000 | 0 | 73,787 | 61.8 K to 73.8 K (+19.42 %) |
| Feb 26 2019 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Payment of Exercise | F | 15.51 | 982 | 15,231 | 61,787 | 62.8 K to 61.8 K (-1.56 %) |
| Jan 08 2019 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Payment of Exercise | F | 16.19 | 3,555 | 57,555 | 62,769 | 66.3 K to 62.8 K (-5.36 %) |
| Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Option Exercise | A | 21.00 | 24,000 | 504,000 | 24,000 | |
| Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Payment of Exercise | F | 21.00 | 4,193 | 88,053 | 66,324 | 70.5 K to 66.3 K (-5.95 %) |
| Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Grant | A | 0.00 | 12,000 | 0 | 70,517 | 58.5 K to 70.5 K (+20.51 %) |
| Mar 06 2018 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Grant | A | 0.00 | 10,000 | 0 | 58,517 | 48.5 K to 58.5 K (+20.61 %) |
| May 10 2017 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Payment of Exercise | F | 18.55 | 3,483 | 64,610 | 48,517 | 52 K to 48.5 K (-6.70 %) |
| Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Option Exercise | A | 23.75 | 25,000 | 593,750 | 25,000 | |
| Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Grant | A | 0.00 | 10,000 | 0 | 52,000 | 42 K to 52 K (+23.81 %) |
| Feb 27 2017 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Grant | A | 0.00 | 10,000 | 0 | 42,000 | 32 K to 42 K (+31.25 %) |
| Jan 05 2016 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Option Exercise | A | 28.58 | 45,000 | 1,286,100 | 45,000 | |
| Jan 05 2016 | AVM | AMAG PHARMACEUTICA ... | Grund Nicholas | Chief Commercial Of ... | Grant | A | 0.00 | 32,000 | 0 | 32,000 | 0 to 32 K |
Page: 1